-
Mashup Score: 0SkinCare Physicians - 1 year(s) ago
Dermatologist · Brookline, MassachusettsDirectionsCallWebsiteHOURSOpenYELP(149)3.5COST$$$$YelpYelpYelpYelpYelpYelpYelpYelpYelpOpen YelpRatings & ReviewsI have been coming here almost 20 years and have no complaints! Dr. Karen Kim is amazing. She is so knowledgeable and efficient, but, just as important, she really cares about her patients (and it shoMoreOn three, yes THREE (3) separate occasions,…
Source: maps.apple.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 5Osteosarcoma Project - 2 year(s) ago
By generating the most comprehensive osteosarcoma database, we can accelerate research and the development of new therapies. Only you hold the key to unlock future discoveries. You can help drive discoveries …
Source: osproject.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Excited that the https://t.co/cCaK0hGp7i patient/family - partnered osteosarcoma study enters a new phase today providing participants with the option to receive information about their tumor and germline sequencing and more opportunities to engage. https://t.co/OpAJl7WTb2
-
-
Mashup Score: 0
Clinically significant genomic alterations were identified in pediatric tumors using molecular tumor profiling.
Categories: Hem/Oncs, Latest HeadlinesTweet-
Thank you @CD_AACR for featuring recent work with @AlannaChurch_MD https://t.co/orVlAxnbeq
-
-
Mashup Score: 6Precision Oncology in Sarcomas: Divide and Conquer - 2 year(s) ago
Sarcomas are a heterogeneous group of rare malignancies that exhibit remarkable heterogeneity, with more than 50 subtypes recognized. Advances in next-generation sequencing technology have resulted in the discovery of genetic events in these mesenchymal tumors, which in addition to enhancing understanding of the biology, have opened up avenues for molecularly targeted therapy and immunotherapy….
Source: JCO Precision OncologyCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @VivekSubbiah: Precision Oncology in Sarcomas: Divide and Conquer @JCOPO_ASCO @PestanaRC @OncoAlert https://t.co/oo694HCdZo
-
-
Mashup Score: 0Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer - Nature Medicine - 2 year(s) ago
An interim report from the GAIN/iCat2 study shows that molecular profiling of pediatric solid malignancies clarifies diagnostic classifications and provides opportunities for matched targeted therapy.
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet-
Excited #CCDI Molecular characterization initiative of @COGorg now enrolling #sarcoma! Molecular tumor profiling of enrolled patients @nationwidekids is similar DNA and RNA sequencing as our study just published in @NatureMedicine showing clinical benefit: https://t.co/BslVmPaK7a https://t.co/4ZcrFXfVtm
-
SkinCare Physicians https://t.co/FMD0n9dB0P